Oral GS-441524 derivatives: Next-generation inhibitors of SARS‐CoV‐2 RNA‐dependent RNA polymerase
出版年份 2022 全文链接
标题
Oral GS-441524 derivatives: Next-generation inhibitors of SARS‐CoV‐2 RNA‐dependent RNA polymerase
作者
关键词
-
出版物
Frontiers in Immunology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-12-06
DOI
10.3389/fimmu.2022.1015355
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae
- (2022) Yapeng Su et al. CELL
- Recent Developments for the Deuterium and Tritium Labeling of Organic Molecules
- (2022) Sara Kopf et al. CHEMICAL REVIEWS
- The mechanism of multiple organ dysfunction syndrome in patients with COVID‐19
- (2022) Wenbin Zhao et al. JOURNAL OF MEDICAL VIROLOGY
- An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
- (2022) Laura A. VanBlargan et al. NATURE MEDICINE
- Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
- (2022) Shiho Chiba et al. mBio
- A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase
- (2022) Ashleigh Shannon et al. Nature Communications
- COVID-19 can be called a treatable disease only after we have antivirals
- (2022) Xueyang Zhang et al. Science Bulletin
- Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects
- (2022) Hong-jie Qian et al. ACTA PHARMACOLOGICA SINICA
- Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID ‐19: A self‐controlled case series study
- (2022) Carlos K. H. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Journey of remdesivir from the inhibition of hepatitis C virus to the treatment of COVID-19
- (2022) Tomas Cihlar et al. ANTIVIRAL THERAPY
- The potential of remdesivir to affect function, metabolism and proliferation of cardiac and kidney cells in vitro
- (2022) Katja Merches et al. ARCHIVES OF TOXICOLOGY
- Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients
- (2022) Ronza Najjar-Debbiny et al. CLINICAL INFECTIOUS DISEASES
- Nirmatrelvir Plus Ritonavir: First Approval
- (2022) Yvette N. Lamb DRUGS
- Comparative bioavailability study following a single dose intravenous and buccal administration of remdesivir in rabbits
- (2022) Lajos Szente et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures
- (2022) Winston Chiu et al. JOURNAL OF MEDICAL VIROLOGY
- Remdesivir treatment in hospitalized patients affected by COVID‐19 pneumonia: A case‐control study
- (2022) Lucio Boglione et al. JOURNAL OF MEDICAL VIROLOGY
- Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
- (2022) Yuto Unoh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach
- (2022) Rafael Dal-Ré et al. LANCET INFECTIOUS DISEASES
- Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses
- (2022) Jeffrey A. Tomalka et al. NATURE IMMUNOLOGY
- Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms
- (2022) Laura J. Stevens et al. Science Translational Medicine
- The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants
- (2022) Liu Cao et al. Science Translational Medicine
- Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice
- (2022) Alexandra Schäfer et al. Science Translational Medicine
- Covid-19: What is the evidence for the antiviral molnupiravir?
- (2022) Andy Extance BMJ-British Medical Journal
- An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants
- (2022) Yinzhong Shen et al. Emerging Microbes & Infections
- The future of Paxlovid for COVID-19
- (2022) Talha Burki Lancet Respiratory Medicine
- Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay
- (2022) Xiaoming Bai et al. Frontiers in Immunology
- Nucleoside analog GS‐441524: pharmacokinetics in different species, safety, and potential effectiveness against Covid‐19
- (2022) Henrik Berg Rasmussen et al. Pharmacology Research & Perspectives
- The Life of SARS-CoV-2 Inside Cells: Replication–Transcription Complex Assembly and Function
- (2022) Zhiyong Lou et al. Annual Review of Biochemistry
- Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
- (2022) Aekkachai Tuekprakhon et al. CELL
- From Positive to Negative to Positive Again—The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid
- (2022) Rita Rubin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection
- (2022) Fangfang Sun et al. LANCET INFECTIOUS DISEASES
- Remdesivir impairs mouse preimplantation embryo development at therapeutic concentrations
- (2022) Yusuke Marikawa et al. REPRODUCTIVE TOXICOLOGY
- Synthesis and anti-SARS-CoV-2 activity of deuterated GS-441524 analogs
- (2022) Wei Zheng et al. TETRAHEDRON LETTERS
- Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment
- (2022) Amy Q. Wang et al. Frontiers in Pharmacology
- Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022
- (2022) Deborah E. Malden et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Biotransformation and transplacental transfer of the anti-viral remdesivir and predominant metabolite, GS-441524 in pregnant rats
- (2022) Ling Yang et al. EBioMedicine
- Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue
- (2022) Zhonglei Wang et al. Frontiers in Public Health
- An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: Promises and challenges
- (2022) Xiaoying Xu et al. BIOCHEMICAL PHARMACOLOGY
- A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors
- (2022) Liming Yan et al. CELL
- Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2022) Saye H Khoo et al. LANCET INFECTIOUS DISEASES
- Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir
- (2022) Dinah V. Parums MEDICAL SCIENCE MONITOR
- Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials
- (2022) Zhenchao Wu et al. Frontiers in Pharmacology
- Bioactive natural products in COVID-19 therapy
- (2022) Zhonglei Wang et al. Frontiers in Pharmacology
- Druggable targets and therapeutic development for COVID-19
- (2022) Xiaohua Duan et al. Frontiers in Chemistry
- The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial
- (2022) Weijie Zhong et al. Frontiers in Medicine
- Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts
- (2021) Zhonglei Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models
- (2021) Yingjun Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
- (2021) Angela Wahl et al. NATURE
- Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
- (2021) Rita Humeniuk et al. CLINICAL PHARMACOKINETICS
- β-D-N 4-hydroxycytidine (NHC) Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
- (2021) Shuntai Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV
- (2021) Richard L. Mackman et al. JOURNAL OF MEDICINAL CHEMISTRY
- High-dimensional characterization of post-acute sequelae of COVID-19
- (2021) Ziyad Al-Aly et al. NATURE
- Post-acute COVID-19 syndrome
- (2021) Ani Nalbandian et al. NATURE MEDICINE
- Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP
- (2021) Mahamaya Biswal et al. NUCLEIC ACIDS RESEARCH
- Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
- (2021) Jiashu Xie et al. Acta Pharmaceutica Sinica B
- Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola
- (2021) Victoria C. Yan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver
- (2021) Victoria C. Yan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2
- (2021) Tofael Ahmed Sumon et al. AQUACULTURE
- Potency and pharmacokinetics of GS-441524 derivatives against SARS-CoV-2
- (2021) Daibao Wei et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Drug metabolic stability in early drug discovery to develop potential lead compounds
- (2021) Siva Nageswara Rao Gajula et al. DRUG METABOLISM REVIEWS
- Cyanorona-20: The first potent anti-SARS-CoV-2 agent
- (2021) Amgad M. Rabie INTERNATIONAL IMMUNOPHARMACOLOGY
- Rational Alteration of Pharmacokinetics of Chiral Fluorinated and Deuterated Derivatives of Emixustat for Retinal Therapy
- (2021) Eliav Blum et al. JOURNAL OF MEDICINAL CHEMISTRY
- Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
- (2021) Florence Ader et al. LANCET INFECTIOUS DISEASES
- Structural biology of SARS-CoV-2 and implications for therapeutic development
- (2021) Haitao Yang et al. NATURE REVIEWS MICROBIOLOGY
- Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
- (2021) Nir Drayman et al. SCIENCE
- Overview of SARS-CoV-2 genome-encoded proteins
- (2021) Chongzhi Bai et al. Science China-Life Sciences
- Cellular Uptake and Intracellular Phosphorylation of GS-441524: Implications for Its Effectiveness against COVID-19
- (2021) Henrik Berg Rasmussen et al. Viruses-Basel
- Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer
- (2021) Liyan Yang et al. Biomedicines
- Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System
- (2021) Concetta Rafaniello et al. Pharmaceuticals
- RdRp inhibitors and COVID-19: Is molnupiravir a good option?
- (2021) Seyed Mohammad Reza Hashemian et al. BIOMEDICINE & PHARMACOTHERAPY
- Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review
- (2021) Maryam Nabati et al. Cardiovascular Toxicology
- Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2
- (2021) Yuanchao Xie et al. CELL RESEARCH
- Human carboxylesterase 1A plays a predominant role in the hydrolytic activation of remdesivir in humans
- (2021) Feng Zhang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Exploration for the effect of renal function and renal replacement therapy on pharmacokinetics of remdesivir and GS‐441524 in patients with COVID‐19: A limited case series
- (2021) Pyoeng Gyun Choe et al. CTS-Clinical and Translational Science
- In the age of Omicron variant: Paxlovid raises new hopes of COVID‐19 recovery
- (2021) Zhonglei Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Broad‐spectrum prodrugs with anti‐SARS‐CoV‐2 activities: Strategies, benefits, and challenges
- (2021) Zhonglei Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
- (2021) Robert L. Gottlieb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524
- (2021) Daniela Krentz et al. Viruses-Basel
- Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
- (2021) Robert M. Cox et al. Nature Communications
- Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection
- (2021) Jiapeng Li et al. Pharmaceutics
- Broad-Spectrum In Vitro Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)
- (2021) Michael K. Lo et al. Microbiology Spectrum
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for RNA replication by the SARS-CoV-2 polymerase
- (2020) Quan Wang et al. CELL
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Structure of replicating SARS-CoV-2 polymerase
- (2020) Hauke S. Hillen et al. NATURE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- Remdesivir in covid-19
- (2020) Robin E Ferner et al. BMJ-British Medical Journal
- Structural and biochemical characterization of nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2
- (2020) Qi Peng et al. Cell Reports
- Hepatic disorders with the use of remdesivir for coronavirus 2019 (COVID-19)
- (2020) François Montastruc et al. Clinical Gastroenterology and Hepatology
- Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects
- (2020) Rita Humeniuk et al. CTS-Clinical and Translational Science
- Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19
- (2020) Massimo Tempestilli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- RNA‐dependent RNA polymerase of SARS‐CoV‐2 as a therapeutic target
- (2020) Yanyan Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection
- (2020) Zhonglei Wang et al. Frontiers in Pharmacology
- Catalytic Asymmetric Synthesis of the anti‐COVID‐19 Drug Remdesivir
- (2020) Mo Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis
- (2020) Liming Yan et al. CELL
- Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database
- (2020) Alexandre O. Gérard et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Architecture of a SARS-CoV-2 mini replication and transcription complex
- (2020) Liming Yan et al. Nature Communications
- Applications of deuterium in medicinal chemistry
- (2019) Tracey Pirali et al. JOURNAL OF MEDICINAL CHEMISTRY
- Advances in Nanoparticulate Drug Delivery Approaches for Sublingual and Buccal Administration
- (2019) Susan Hua Frontiers in Pharmacology
- The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies
- (2018) B.G. Murphy et al. VETERINARY MICROBIOLOGY
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- FDA approves first deuterated drug
- (2017) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses
- (2015) Kathleen C. Lehmann et al. NUCLEIC ACIDS RESEARCH
- Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides
- (2012) Aesop Cho et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started